microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02964351

Enrollment

120

Registered

2016-11-16

Start date

2016-12-31

Completion date

2018-12-31

Last updated

2016-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Carcinosarcoma

Keywords

MicroRNA, Prostate Carcinoma, PET-MR

Brief summary

In our study, the investigators want to find correlation between circulating miRNAs associated with prostate cancer metastases to bones and to lymph nodes separately with results of 68Ga-PSMA ligand PET (positron emission computed) imaging.

Interventions

BIOLOGICALHigh PSA levels

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Proven Adeno-carcinoma * Underwent prostatectomy and still present high PSA levels * Refered to PSMA exam.

Exclusion criteria

* Below 18 years old * HIV/HBV (hepatitis B virus)/HCV (hepatitis C virus) positive * Additional malignancy during the past five years.

Design outcomes

Primary

Measure	Time frame	Description
Metastasis size and location	18 months	Location of metastasis by a report analyzing the pathological examination (PET-MR output).

Secondary

Measure	Time frame	Description
MicroRNA profile by using Nano-string technology validated by real time PCR	24 months	Validation of MicroRNA pattern by using real time PCR

Contacts

Primary ContactNatalia Goldberg, MD

natalia.goldberg@gmail.com972547833789

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026